Long-term Care and Drug Benefits Under Health Care Reform: Hearing Before the Committee on Finance, United States Senate, One Hundred Third Congress, Second Session, April 14, 1994, Volume 4 |
Contents
Moynihan Hon Daniel Patrick a U S Senator from New York chairman | 1 |
BricelandBetts Deborah national director the Long Term Care Campaign | 11 |
Rudnick Seth A M D chairman of the board and chief executive officer | 41 |
Copyright | |
5 other sections not shown
Other editions - View all
Common terms and phrases
AARP Administration's adult day health Alzheimer's Alzheimer's Disease Americans believe biotechnology breakthrough drugs BRICELAND-BETTS ceutical CHAIRMAN Clinton Committee community pharmacies companies competition Congress consumer cost containment disabled discounts disease dollars drug prices drug products elderly eligibility expenditures federal financing formularies funding Glaxo going health care reform health care system Health Security Act HMOs home and community home and community-based home care hospital income increase individuals inflation innovation long term health long-term care insurance long-term care services managed care pharmacy marketplace Medicaid Medicare beneficiaries Medicare prescription drug Medigap mg tab million National nursing home patients percent pharmaceutical industry premiums prescription drug benefit President's proposal price controls price discrimination private insurance problem protection purchase question rebate research and development Rudnick SANDERS savings Senator CHAFEE Senator HATCH Senator PACKWOOD Senator Pryor term care therapeutic therapies tion